Trade Bull Master
The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the Novavax COVID-19 vaccine, a protein-subunit vaccine representing a different technological approach compared to the mRNA vaccines already widely deployed. However, this approval comes with significant and unusual restrictions, raising questions about its potential impact and market …
Read More »How to Decipher the FDA’s Novavax Approval
